The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage.
D000595:Amino Acid Sequence; D001471:Barrett Esophagus / Q000378:metabolism* / Q000473:pathology; D002453:Cell Cycle; D002470:Cell Survival; D003114:Colony-Forming Units Assay; D004249:DNA Damage; D015180:Electrophoresis, Gel, Two-Dimensional; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism; D020868:Gene Silencing; D006801:Humans; D007414:Intestinal Neoplasms / Q000378:metabolism* / Q000473:pathology; D013058:Mass Spectrometry; D008679:Metaplasia / Q000378:metabolism / Q000473:pathology; D008969:Molecular Sequence Data; D010766:Phosphorylation; D019704:Protein Disulfide-Isomerases; D017386:Sequence Homology, Amino Acid; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D014466:Ultraviolet Rays; D029867:Xenopus Proteins / Q000502:physiology*
D016159:Tumor Suppressor Protein p53; D029867:Xenopus Proteins; D019704:Protein Disulfide-Isomerases; C113451:XAG-2 protein, Xenopus